Stifel Financial’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-38,781
Closed -$46K 3420
2022
Q3
$46K Sell
38,781
-1,340
-3% -$1.59K ﹤0.01% 3189
2022
Q2
$72K Buy
40,121
+12,133
+43% +$21.8K ﹤0.01% 3192
2022
Q1
$57K Buy
27,988
+5,215
+23% +$10.6K ﹤0.01% 3300
2021
Q4
$62K Sell
22,773
-4,495
-16% -$12.2K ﹤0.01% 3297
2021
Q3
$122K Sell
27,268
-1,709
-6% -$7.65K ﹤0.01% 3222
2021
Q2
$168K Buy
28,977
+163
+0.6% +$945 ﹤0.01% 3167
2021
Q1
$202K Sell
28,814
-7,548
-21% -$52.9K ﹤0.01% 3015
2020
Q4
$175K Sell
36,362
-1,911
-5% -$9.2K ﹤0.01% 2854
2020
Q3
$223K Sell
38,273
-2,617
-6% -$15.2K ﹤0.01% 2565
2020
Q2
$276K Buy
40,890
+7,292
+22% +$49.2K ﹤0.01% 2405
2020
Q1
$210K Buy
33,598
+7,481
+29% +$46.8K ﹤0.01% 2410
2019
Q4
$272K Buy
+26,117
New +$272K ﹤0.01% 2590
2019
Q2
Sell
-12,703
Closed -$315K 3083
2019
Q1
$315K Buy
12,703
+386
+3% +$9.57K ﹤0.01% 2332
2018
Q4
$219K Sell
12,317
-6,178
-33% -$110K ﹤0.01% 2416
2018
Q3
$537K Sell
18,495
-7,139
-28% -$207K ﹤0.01% 2054
2018
Q2
$1.17M Buy
25,634
+6,732
+36% +$307K ﹤0.01% 1510
2018
Q1
$997K Buy
18,902
+2,954
+19% +$156K ﹤0.01% 1565
2017
Q4
$1.09M Buy
15,948
+1,020
+7% +$69.4K ﹤0.01% 1480
2017
Q3
$1.22M Sell
14,928
-1,889
-11% -$155K ﹤0.01% 1382
2017
Q2
$1.58M Buy
16,817
+3,838
+30% +$359K 0.01% 1213
2017
Q1
$825K Sell
12,979
-38
-0.3% -$2.42K ﹤0.01% 1538
2016
Q4
$579K Sell
13,017
-2,053
-14% -$91.3K ﹤0.01% 1699
2016
Q3
$551K Buy
+15,070
New +$551K ﹤0.01% 1675
2016
Q2
Sell
-14,936
Closed -$287K 2582
2016
Q1
$287K Buy
14,936
+6,271
+72% +$120K ﹤0.01% 1838
2015
Q4
$303K Buy
8,665
+3,761
+77% +$132K ﹤0.01% 1909
2015
Q3
$451K Buy
4,904
+876
+22% +$80.6K ﹤0.01% 1623
2015
Q2
$354K Buy
+4,028
New +$354K ﹤0.01% 1867
2015
Q1
Sell
-4,132
Closed -$231K 2387
2014
Q4
$231K Buy
+4,132
New +$231K ﹤0.01% 1998